Dunedin-based cancer diagnostic company Pacific Edge has appointed Mark Green as an independent director.
Mr Green has about 25 years’ experience in the Australasian capital, corporate and financial markets and was an executive director of investment banking at Goldman Sachs, where he worked for nearly 20 years.
He has been involved in many large New Zealand transactions, including the IPOs of Meridian, Mighty River Power and Vector. He is chairman of the Astrolab VC Investment Committee and a director of Mariposa Holdings.
Mr Green said Pacific Edge was an "exciting’’ New Zealand company seeking to lead the way in cancer diagnostics.
"It is a company that has sought to protect its intellectual property and to add value not only to its shareholders and other corporate stakeholders but also to New Zealand.
"It is a privilege to be involved with such a company," he said.
Pacific Edge chairman Chris Gallaher said the company was pleased to welcome him on to the board. His appointment continued a rejuvenation process that was under way.
"Mark’s appointment fills a skills need identified by the board and he will be a strong contributor to both the board and the company as we continue on our growth pathway."
Mr Green will hold office until the cancer diagnostic company’s 2021 annual meeting, when he will offer himself for election by shareholders.
